UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000001561
Receipt number R000001887
Scientific Title Pilot Study of Leuprorelin for Gynecologic Malignancies
Date of disclosure of the study information 2008/12/10
Last modified on 2011/12/10 09:55:17

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Pilot Study of Leuprorelin for Gynecologic Malignancies

Acronym

Leuprorelin for Gynecologic Malignancies

Scientific Title

Pilot Study of Leuprorelin for Gynecologic Malignancies

Scientific Title:Acronym

Leuprorelin for Gynecologic Malignancies

Region

Japan


Condition

Condition

Advanced / recurrent gynecologic malignancies

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To determine the efficacy of leuprolerin for the Japanese patients with gynecologic malignancies in the palliative setting, and to identify the favorable subgroup by translational research

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase II


Assessment

Primary outcomes

Symtom stabilization at 8 weeks

Key secondary outcomes

progression free survival, overall survival, response rate, qaulity of life


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

leuprolerin S.C.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

1) refractory/ resistant Mullerian carcinoma(epithelial ovarian carcinoma, tubal carcinoma, and primary peritoneal carcinoma)
2) advanced/ recurrent other gynecologic malignancies

Key exclusion criteria

Performance status > 2 (ECOG)

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hiroshi Tsubamoto

Organization

Hyogo College of Medicine

Division name

Obstetrics and Gynecology

Zip code


Address

Mukogawa 1-1, Nishinomiya, Hyogo

TEL

0798-45-6481

Email



Public contact

Name of contact person

1st name
Middle name
Last name Hiroshi Tsubamoto

Organization

Hyogo College of Medicine

Division name

Obstetrics and Gynecology

Zip code


Address

Mukogawa 1-1, Nishinomiya, Hyogo

TEL

0798-45-6481

Homepage URL


Email

tsuba@hyo-med.ac.jp


Sponsor or person

Institute

Department of Ostetrics and Gnecology, Hyogo College of Medicine

Institute

Department

Personal name



Funding Source

Organization

Hyogo College of Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2008 Year 12 Month 10 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2008 Year 12 Month 10 Day

Date of IRB


Anticipated trial start date

2008 Year 12 Month 01 Day

Last follow-up date

2012 Year 12 Month 01 Day

Date of closure to data entry

2012 Year 12 Month 01 Day

Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2008 Year 12 Month 10 Day

Last modified on

2011 Year 12 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001887


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name